Voloridge Investment Management
ASTH icon

Voloridge Investment Management’s Astrana Health ASTH Stock Holding History

Voloridge Investment Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,565
Closed -$1.04M – 1667
2022
Q1 		$1.04M Sell
21,565
-25,231
-54% -$1.3M 0.01% 1119
2021
Q4 		$3.44M Sell
46,796
-86,663
-65% -$7.12M 0.02% 864
2021
Q3 		$12.2M Buy
+133,459
New +$11.3M 0.08% 365

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Voloridge Investment Management's ASTH Position: Q2 2022 in Review

Voloridge Investment Management sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 21,565 shares — an estimated $1.04M sold.

Voloridge Investment Management first reported a position in ASTH in Q3 2021 and held it in 3 quarters. The position peaked at $12.2M in Q3 2021. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • Voloridge Investment Management reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 21,565 Astrana Health shares in Q2 2022, an estimated $1.04M.
  • Voloridge Investment Management first reported a position in Astrana Health in Q3 2021 and held it in 3 quarters.
  • Voloridge Investment Management's Astrana Health position peaked at $12.2M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Voloridge Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.